Review
Open access
Oct 2026
Molecular and immune-mediated resistance to antibody-drug conjugates in breast cancer
Antibody-drug conjugates (ADCs) have progressively advanced the conceptual framework of targeted oncology, evolving from a way to deliver chemotherapy selectively to tumor cells into drugs that also interact with the immune system to support their action. In breast cancer, the approval of several novel ADCs has transfo...
A. Mattana, C. Veronese, Julia Penitenti et al.
· Frontiers in Immunology · 0 citations